Archiv

 

Veranstaltungen 2011

 

Jänner 2011, Innsbruck, AT

Integrated Management of Acute and Chronic CAD, Innsbruck

gemeinsam mit der WG on Thrombosis der ESC

 

 

 

März 2011, Wien, AT

Update in Rhythmology

Part der antithrombotischen Therapie

 

Juni 2011, Salzburg, AT

Jahrestagung der ÖKG

Organisation von 2 Symposien

 

19. 11. 2011, Wien, AT

Antithrombotische Therapie bei Herz-Kreislauferkrankungen

Kardiologische Seminare Wilhelminenberg

 

 

20.11.– 21.11.2011, Solingen, DE 

Joint meeting with the WG on Coronary Revascularisation of the DKG

 

 

Veranstaltungen 2010

 

Jänner 2010, Weissensee, AT

Joint meeting with the WG on Experimental Cardiology and Cardiovascular Surgery

Co-organizer Johann Wojta

 

Juni 2010, ÖKG,Salzburg, AT

Organisation von 2 Symposien

 

Juni 2010, Bad Horn, CH

Writing group expert meeting

Perioperative Strategies in Patients on Antiplatelet Therapy

Publikation in Thromb Haemost 2010/11, Huber et al

 

Juli 2010, Wien, AT

Consensus/Expert-Meeting

High-sensitive Troponins in daily Routine

Karl Mulac, Kurt Huber

 

September 2010, Graz, AT

Joint meeting with the Austrian Society of Anaesthesiology

Perioperative Strategies in Patients under Antithrombotic Therapy

Kurt Huber, Helfried Metzler

 

September 2010, Wien, AT

ALPE ADRIA CARDIOLOGY-Meeting

2 symposia about "Antithrombotic Therapy", 1 symposium about vascular biology

Organization and co-organization by Kurt Huber and Johann Wojta

 

November 2010, Solingen, DE

Joint meeting with the WG on Coronary Revascularisation of the DKG

 

 

 

 

 

 

Veranstaltungen 2009

 

Coronary Reperfusion and Secondary Prevention, Oberlech, 21.-26.3.2009

 

Oktober 2009, Oslo, NO

EuroThrombosis Summit meeting

together with the WG on Thrombosis of the ESC

Co-organizers: Johann Wojta, Kurt Huber

 

November 2009, München, DE

PCI-Meeting

Co-organizer Kurt Huber (responsible for topics: antithrombotic therapy)

 

November 2009, Solingen, DE

Joint meeting with the WG on Coronary Revascularization of the DKG

H-M Hoffmeister, Kurt Huber

 

 

November 2009, Wien, AT

Antithrombotische Therapie bei Herzerkrankungen

Kurt Huber, Harald Darius

 

Veranstaltungen/Fortbildungen 2007

• ÖKG-Sitzung bei der ÖKG-Tagung 2007
• Coronary reperfusion and secondary prevention; Oberlech, 14.-19.4.2007
• Kardiologisch-hämostaseologischer Workshop; Solingen, 11.-12.11.2007 (gemeinsam mit AG Thrombose der ÖKG)
• Antithrombotische Therapie bei kardialen Erkrankungen; Wien, 27.11.2007

 

Scientific Highlights

 

Dr. Jolanta Siller-Matula

ESC-Pressekonferenz 29. August 2010, Stockholm

What's new in antiplatelet therapy?

 

Mitarbeit an Studien:

HORIZON S, RE-LY; TRITON TIMI-38 (PPI Substudy), APPRAISE-1, SEPIA ACS-1, ATLAS-2

präsentiert am AHA 2009

 

Publikationen

 

• K. Huber et al.
  Perioperative Strategies in Patients on Antiplatelet Therapy
  Publikation in Thromb Haemost 2010/11
• Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.Circulation. 2007 Oct 30;116(18):2043-52.
• Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.Circulation. 2007 May 29;115(21):2745-9.
• Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C, Biamino G, Vermassen F, Scheinert D, van Sambeek MR, Schillinger M. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries.Eur Heart J. 2007 Apr;28(7):798-805.
• Rega G, Kaun C, Demyanets S, Pfaffenberger S, Rychli K, Hohensinner PJ, Kastl SP, Speidl WS, Weiss TW, Breuss JM, Furnkranz A, Uhrin P, Zaujec J, Zilberfarb V, Frey M, Roehle R, Maurer G, Huber K, Wojta J. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1587-95.
• Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.Cardiovasc Res. 2007 Jul 15;75(2):417-25.
• G. Christ, K. Huber, et al
  Positionspapier "Perioperative antithrombotische Strategien bei Patienten unter dualer Antiplättchentherapie (AG Interventionelle Kardiologie und AG ATVB) (2009)
• Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost. 2011 May;105(5):743-9
• Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KA, Kristensen SD, Rao SV, Verheugt FW, Widimsky P, Zeymer U, Collet JP. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011 Aug;32(15):1854-64. 

 

Forschungsprojekte

• Impact of glycemic control and insulin resistance on the rate of instent restenosis in diabetic patients after drug eluting stent implantation. (LBI-Cluster for Cardiovascular Research, KH)
• Angiogenese im Fettgewebe: Eine Verbindung zwischen Adipositas und kardiovaskulären Erkrankungen? (LBI-Cluster for Cardiovascular Research, JW)
• Angiogenesis and disease: Regulation of mediators of tissue repair and angiogenesis in human hearts (FWF Forschungsschwerpunkt NFN94, JW)
• The role of progenitor-cells in atherosclerotic lesion formation and vascular repair: Modulation by angiogenic growth factors (ATVB, WS)
• Angiogenesis and Inflammation in Adipose Tissue: A link between obesity and cardiovascular disease
• Impact of Glycemic Control and Insulin Resistance in Patients with Stable and Unstable Coronary Artery Disease
• New Biomarkers in Coronary Artery Disease and Heart Failure (Co-Peptin, Adrenomedullin, Cystatin C) 
• Platelet Function Testing after Coronary Stent Implantation